Amylyx Pharmaceuticals, Inc. (AMLX)

USD 3.94

(-7.94%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019
Total Assets 517.45 Million 391.45 Million 105.61 Million 14.1 Million 3.22 Million
Total Current Assets 464.66 Million 382.13 Million 101.51 Million 13.63 Million 3.2 Million
Cash And Short Term Investments 371.36 Million 346.94 Million 96.11 Million 12.87 Million 3.09 Million
Cash and Cash Equivalents 170.2 Million 62.52 Million 50.19 Million 12.87 Million 3.09 Million
Short Term Investments 201.16 Million 284.41 Million 45.92 Million - -
Net Receivables 40.05 Million 15.3 Million - - -
Inventory 38.32 Million 9.76 Million - - -
Other Current Assets 14.93 Million 10.11 Million 5.39 Million 762 Thousand 111 Thousand
Total Non-Current Assets 52.78 Million 9.31 Million 4.1 Million 464.99 Thousand 18 Thousand
Net PPE 6.41 Million 8.13 Million 474 Thousand 151 Thousand -
Good Will And Intangible Assets - - - - -
Good Will - - - - -
Intangible Assets - - - - -
Long-Term Investments 719 Thousand 719 Thousand 189 Thousand 189 Thousand -
Tax Assets - - - - -
Other Non Current Assets 45.65 Million 465.99 Thousand 3.44 Million 124.99 Thousand 18 Thousand
Other Assets - 1.00 1.00 1.00 -
Total Liabilities 84.02 Million 50.84 Million 256.78 Million 80.82 Million 28.57 Million
Total Current Liabilities 82.04 Million 46.6 Million 17.39 Million 7.32 Million 4.52 Million
Account Payables 22.06 Million 46.6 Million 17.39 Million 3.61 Million 2.19 Million
Tax Payables - - - - -
Short Term Debt 2.25 Million 2.04 Million - - -
Deferred Revenue - - - - -
Other Current Liabilities 57.72 Million -2.04 Million - 3.71 Million 2.33 Million
Total Non Current Liabilities 1.98 Million 4.23 Million 239.38 Million 73.5 Million 24.04 Million
Long-Term Debt 1.98 Million 4.23 Million - 1.42 Million 14.93 Million
Deferred Revenue Non Current - - 35 Thousand 14 Thousand 4000.00
Deferred Tax Liabilities Non Current - - - - -
Other Non Current Liabilities - - 239.35 Million 72.06 Million 9.11 Million
Other Liabilities - - - - -
Total Equity 433.43 Million 340.6 Million -151.16 Million -66.72 Million -25.35 Million
Stock Holders Equity 433.43 Million 340.6 Million -151.16 Million -66.72 Million -25.35 Million
Common Stock 7000.00 7000.00 1000.00 1000.00 1000.00
Retained Earnings -304.94 Million -354.22 Million -155.84 Million -67.91 Million -25.63 Million
Accumulated other comprehensive income 197 Thousand -86 Thousand 9000.00 -72.06 Million -7.67 Million
Common Stock Equity 433.43 Million 340.6 Million -151.16 Million -66.72 Million -25.35 Million
Capital Lease Obligation 4.23 Million 6.27 Million - - -
Total Investments 201.16 Million 284.41 Million 45.92 Million 189 Thousand -
Total Debt 4.23 Million 6.27 Million - 1.42 Million 14.93 Million
Net Debt -165.96 Million -56.24 Million -50.19 Million -11.45 Million 11.84 Million

Balance Sheet Charts